Global tumor ablation market is expected to reach USD 1.5 billion by 2022,
according to a new study by Grand View Research Inc. Rising prevalence of
different forms of cancer and increasing technological advancements in the
field of thermal ablation techniques are the most prominent drivers of the
market.
Besides the use of thermal ablation, techniques such as laser ablation,
irreversible electroporation, High Intensity Focused Ultrasonography (HIFU) are
also clinically growing, concurrently propelling the tumor ablation
industry.
Occurrence of lung, breast, and liver cancer is on the rise globally.
According to the Center for Disease Control (CDC) and other organizations,
currently, about 210,828 cases of lung cancer, 2.9 million cases of breast
cancer, and over 2.7 million cases of prostate cancer are reported in the U.S.
alone.
In terms of technological advancement, companies such as SonaCare Medical
are coupling ablation techniques with other technologies to improve accuracy,
performance, and level of care. SonaLink, a remote patient monitoring platform,
was put to use along with Sonatherm ablation system to enable physicians to
enhance patient care experience, thereby promoting market growth.
The industry is also anticipated to witness mergers and joint collaborations
as a tool to curb rising competition. For instance, Boston Scientific
Corporation acquired C.R. Bard Electrophysiology, which led to a 48.0% hike in
profit for the former company.
View summary of this report @ http://www.grandviewresearch.com/industry-analysis/tumor-ablation-market
Further key findings from the study suggest:
- Microwave ablation technology is expected to be the fastest growing segment over the forecast period at a CAGR of over 15.0%. Reduction in the procedure time and low cost for treatment are some of the attributes favoring growth.
- In terms of treatment, surgical ablation is predicted to form the largest market by 2022 with about 35.0% share. Liver and lung cancer ablation require surgical procedures, and since these form the largest and fastest growing segments, they concomitantly propel surgical ablation growth.
- Lung cancer forms the most lucrative market and is anticipated to be the fastest growing segment over the forecast period. By 2022, it is expected to contribute about 15.0% of the revenue share owing to its rising prevalence rate across the globe.
- According to market forecast for 2022, North America is expected to dominate the market and Asia Pacific is anticipated to witness the fastest growth. Augmenting growth in the cancer prevalence and rising healthcare expenditure in regions such as China, Korea, and India are factors responsible for this rapid growth.
- Major players of the market include HealthTronics, Galil Medical Inc., Angiodynamics, Medtronic Plc. (Covidien), Boston Scientific Corporation, SonaCare Medical, Misonix Inc., EDAP TMS S.A., and Neuwave Medical Inc. To retain market leadership, players such as Medtronic are working towards acquiring other companies and expanding their portfolio. For instance, in January 2016, Medtronic acquired the OsteoCool RF Ablation System from Baylis Medical.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global tumor ablation market on the basis of technology, treatment, application, and region
Global Tumor Ablation Technology Outlook (USD million), 2012 - 2022
·
Radiofrequency
·
Microwave ablation
·
Cryoablation
·
Other ablation technologies
Global Tumor Ablation Treatment Outlook (USD million), 2012 - 2022
·
Surgical tumor ablation
·
Laparoscopic tumor ablation
·
Percutaneous tumor ablation
Global Tumor Ablation Application Outlook (USD million), 2012 - 2022
·
Liver cancer
·
Breast cancer
·
Lung cancer
·
Prostate cancer
·
Other cancers
Tumor Ablation Region Outlook (USD million), 2012 - 2022
·
North America
o
U.S.
§ U.S.
tumor ablation market technology outlook
§ Radiofrequency
§ Microwave
ablation
§ Cryoablation
§ Other
ablation technologies
§ U.S.
tumor ablation market treatment outlook
§ Surgical
tumor ablation
§ Laparoscopic
tumor ablation
§ Percutaneous
§ U.S.
tumor ablation market application outlook
§ Liver
cancer
§ Breast
cancer
§ Lung
cancer
§ Prostate
cancer
§ Other
cancer
o
Canada
§ Canada
tumor ablation market technology outlook
§ Radiofrequency
§ Microwave
ablation
§ Cryoablation
§ Other
ablation technologies
§ Canada
tumor ablation market treatment outlook
§ Surgical
tumor ablation
§ Laparoscopic
tumor ablation
§ Percutaneous
§ Canada
tumor ablation market application outlook
§ Liver
cancer
§ Breast
cancer
§ Lung
cancer
§ Prostate
cancer
§ Other
cancer
·
Europe
o
UK
§ UK
tumor ablation market technology outlookUK tumor ablation market treatment
outlook
§ Radiofrequency
§ Microwave
ablation
§ Cryoablation
§ Other
ablation technologies
§ Surgical
tumor ablation
§ Laparoscopic
tumor ablation
§ Percutaneous
§ UK
tumor ablation market application outlook
§ Liver
cancer
§ Breast
cancer
§ Lung
cancer
§ Prostate
cancer
§ Other
cancer
o
Germany
§ Germany
tumor ablation market technology outlook
§ Radiofrequency
§ Microwave
ablation
§ Cryoablation
§ Other
ablation technologies
§ Germany
tumor ablation market treatment outlook
§ Surgical
tumor ablation
§ Laparoscopic
tumor ablation
§ Percutaneous
§ Germany
tumor ablation market application outlook
§ Liver
cancer
§ Breast
cancer
§ Lung
cancer
§ Prostate
cancer
§ Other
cancer
·
Asia Pacific
o
Japan
§ Japan
tumor ablation market technology outlook Japan tumor ablation market
treatment outlook
§ Radiofrequency
§ Microwave
ablation
§ Cryoablation
§ Other
ablation technologies
§ Surgical
tumor ablation
§ Laparoscopic
tumor ablation
§ Percutaneous
§ Japan
tumor ablation market application outlook
§ Liver
cancer
§ Breast
cancer
§ Lung
cancer
§ Prostate
cancer
§ Other
cancer
o
China
§ China
tumor ablation market technology outlook
§ Radiofrequency
§ Microwave
ablation
§ Cryoablation
§ Other
ablation technologies
§ China
tumor ablation market treatment outlook
§ Surgical
tumor ablation
§ Laparoscopic
tumor ablation
§ Percutaneous
§ China
tumor ablation market application outlook
§ Liver
cancer
§ Breast
cancer
§ Lung
cancer
§ Prostate
cancer
§ Other
cancer
·
Latin America
o
Brazil
§ Brazil
tumor ablation market technology outlook
§ Radiofrequency
§ Microwave
ablation
§ Cryoablation
§ Other
ablation technologies
§ Brazil
tumor ablation market treatment outlook
§ Surgical
tumor ablation
§ Laparoscopic
tumor ablation
§ Percutaneous
§ Brazil
tumor ablation market application outlook
§ Liver
cancer
§ Breast
cancer
§ Lung
cancer
§ Prostate
cancer
§ Other
cancer
o
Mexico
§ Mexico
tumor ablation market technology outlook
§ Radiofrequency
§ Microwave
ablation
§ Cryoablation
§ Other
ablation technologies
§ Mexico
tumor ablation market treatment outlook
§ Surgical
tumor ablation
§ Laparoscopic
tumor ablation
§ Percutaneous
§ Mexico
tumor ablation market application outlook
§ Liver
cancer
§ Breast
cancer
§ Lung
cancer
§ Prostate
cancer
§ Other
cancer
·
MEA
o
South Africa
§ South
Africa tumor ablation market technology outlook
§ Radiofrequency
§ Microwave
ablation
§ Cryoablation
§ Other
ablation technologies
§ South
Africa tumor ablation market treatment outlook
§ Surgical
tumor ablation
§ Laparoscopic
tumor ablation
§ Percutaneous
§ South
Africa tumor ablation market application outlook
§ Liver
cancer
§ Breast
cancer
§ Lung
cancer
§ Prostate
cancer
§ Other
cancer
o
Saudi Arabia
§ Saudi
Arabia tumor ablation market technology outlook
§ Radiofrequency
§ Microwave
ablation
§ Cryoablation
§ Other
ablation technologies
§ Saudi
Arabia tumor ablation market treatment outlook
§ Surgical
tumor ablation
§ Laparoscopic
tumor ablation
§ Percutaneous
§ Saudi
Arabia tumor ablation market application outlook
§ Liver
cancer
§ Breast
cancer
§ Lung
cancer
§ Prostate
cancer
§ Other
cancer
About Grand View
Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
For More Information Visit - http://www.grandviewresearch.com/
No comments:
Post a Comment